Correction to: miRNA-23b as a biomarker of culture-positive neonatal sepsis

Affiliations

• ¹ Laboratory of Applied Molecular Biology and Immunology, W0414100, Tlemcen, Algeria.
• ² Laboratory of Microbiology Applied in Food, Biomedical and Environment, Tlemcen, Algeria.
• ³ Faculty of Medicine, Tlemcen Medical Centre University, 13000, Tlemcen, Algeria.
• ⁴ Neonatal Department of Specialized Maternal and Child Hospital of Tlemcen, 13000, Tlemcen, Algeria.
• ⁵ Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, Spain.
• ⁶ Mixed Unit for Rare Diseases INCLIVA-CIPF, INCLIVA Health Research Institute, Valencia, Spain.
• ⁷ Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, Avenida Blasco Ibañez 15, 46010, Valencia, Spain.
• ⁸ Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, Spain. federico.v.pallardo@uv.es.
• ⁹ Mixed Unit for Rare Diseases INCLIVA-CIPF, INCLIVA Health Research Institute, Valencia, Spain. federico.v.pallardo@uv.es.
• ¹⁰ Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, Avenida Blasco Ibañez 15, 46010, Valencia, Spain. federico.v.pallardo@uv.es.